ArticleBMJ global health2026
State capacity and health system financing: a cross-country analysis.
Article in BMJ global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionAchieving universal health coverage (UHC) requires not only financial resources but also strong and capable states that can mobilise, allocate and effectively manage those resources. Although fiscal capacity is widely acknowledged as a key determinant of health systems financing, state capacity is a broader, multidimensional construct that encompasses the administrative, legal and coercive functions of the state.
methodsThis study investigates how multiple dimensions of state capacity-bureaucratic quality, corruption, rule of law, military involvement in politics, government effectiveness, property rights and state fragility-are associated with key measures of health financing. We analyse an unbalanced global panel of 141 countries, including 49 low- and middle-income countries, over the period 2000-2020. Using data from established cross-country institutional and health financing sources, we estimate fixed-effects and random-effects panel regression models to assess the relationship between state capacity and the two health financing metrics: government health expenditure per capita and out-of-pocket health spending as a share of current health expenditure, used here as a proxy for financial protection.
resultsOur findings indicate that stronger state capacity is consistently associated with higher public health investment and reduced out-of-pocket spending by households. A 1 SD increase in bureaucratic quality is associated with a 2.6 percentage-point lower share of OOP health expenditure in current health spending. Similarly, 1 SD improvements in government effectiveness and property rights are associated with 1.6 and 2.8 percentage-point lower OOP shares, respectively. A 1 SD increase in rule of law, government effectiveness or property rights is associated with a 13%-31% higher level of government health expenditure (GHE) per capita, whereas a 1 SD increase in state fragility is associated with a 32% lower GHE per capita. The aggregate state capacity index is positively associated with GHE per capita, with a 1 SD increase corresponding to a 17.5% higher level of public health spending.
conclusionThe results underscore the critical role of state institutions in achieving sustainable and equitable health financing and highlight the importance of governance reforms in accelerating progress toward UHC across diverse national contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.